Skip to main content
SpringerLink
Log in

Systemic Lupus Erythematosus: Clinical Aspects

  • Chapter
  • First Online:
Book cover Connective Tissue Disease

Part of the book series: Rare Diseases of the Immune System ((RDIS))

  • 1118 Accesses

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder that results from a combination of genetic, environmental, and hormonal factors. The disease is characterized by a heterogeneous clinical presentation, a different course in different individuals, and a variability in the disease progression/fluctuations within the same patient. The clinical picture of SLE is extremely variable and may be related to disease activity, organ damage, drug toxicity, and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C et al (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67(2):195–205

    Article  CAS  PubMed  Google Scholar 

  2. Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R et al (2010) European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 69(7):1269–1274

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zonana-Nacach A, Roseman JM, McGwin G Jr, Friedman AW, Baethge BA, Reveille JD et al (2000) Systemic lupus erythematosus in three ethnic groups. VI: factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs nurture. Lupus 9(2):101–109

    Article  CAS  PubMed  Google Scholar 

  5. Pettersson S, Lovgren M, Eriksson LE, Moberg C, Svenungsson E, Gunnarsson I et al (2012) An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scand J Rheumatol 41(5):383–390

    Article  CAS  PubMed  Google Scholar 

  6. Burgos PI, Alarcon GS, McGwin G Jr, Crews KQ, Reveille JD, Vila LM (2009) Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. Arthritis Rheum 61(9):1179–1186

    Article  PubMed  PubMed Central  Google Scholar 

  7. Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB (2005) Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol 32(9):1699–1705

    PubMed  Google Scholar 

  8. Tench CM, McCarthy J, McCurdie I, White PD, D’Cruz DP (2003) Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology 42(9):1050–1054

    Article  CAS  PubMed  Google Scholar 

  9. Buskila D, Press J, Abu-Shakra M (2003) Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 25(1):25–28

    Article  PubMed  Google Scholar 

  10. Torrente-Segarra V, Carbonell-Abello J, Castro-Oreiro S, Manresa Dominguez JM (2010) Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus. Clin Exp Rheumatol 28(6 Suppl 63):S22–S26

    CAS  PubMed  Google Scholar 

  11. Friedman AW, Tewi MB, Ahn C, McGwin G Jr, Fessler BJ, Bastian HM et al (2003) Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of fibromyalgia. Lupus 12(4):274–279

    Article  CAS  PubMed  Google Scholar 

  12. Bachen EA, Chesney MA, Criswell LA (2009) Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 61(6):822–829

    Article  PubMed  PubMed Central  Google Scholar 

  13. Meszaros ZS, Perl A, Faraone SV (2012) Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry 73(7):993–1001

    Article  PubMed  Google Scholar 

  14. Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL et al (2010) Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol 37(10):2032–2038

    Article  PubMed  Google Scholar 

  15. Choi ST, Kang JI, Park IH, Lee YW, Song JS, Park YB et al (2012) Subscale analysis of quality of life in patients with systemic lupus erythematosus: association with depression, fatigue, disease activity and damage. Clin Exp Rheumatol 30(5):665–672

    PubMed  Google Scholar 

  16. Moldovan I, Katsaros E, Carr FN, Cooray D, Torralba K, Shinada S et al (2011) The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus 20(12):1285–1292

    Article  CAS  PubMed  Google Scholar 

  17. Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T et al (2006) Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 54(8):2505–2514

    Article  CAS  PubMed  Google Scholar 

  18. Giovacchini G, Mosca M, Manca G, Della Porta M, Neri C, Bombardieri S et al (2010) Cerebral blood flow in depressed patients with systemic lupus erythematosus. J Rheumatol 37(9):1844–1851

    Article  PubMed  Google Scholar 

  19. Newman K, Owlia MB, El-Hemaidi I, Akhtari M (2013) Management of immune cytopenias in patients with systemic lupus erythematosus – old and new. Autoimmun Rev 12(7):784–791

    Article  PubMed  Google Scholar 

  20. Fayyaz A, Igoe A, Kurien BT, Danda D, James JA, Stafford HA et al (2015) Haematological manifestations of lupus. Lupus Sci Med 2(1):e000078

    Article  PubMed  PubMed Central  Google Scholar 

  21. Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D (1978) Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 21(3):295–305

    Article  CAS  PubMed  Google Scholar 

  22. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 33(4):291–437

    Article  CAS  PubMed  Google Scholar 

  23. Arenas M, Abad A, Valverde V, Ferriz P, Pascual R (1992) Selective inhibition of granulopoiesis with severe neutropenia in systemic lupus erythematosus. Arthritis Rheum 35(8):979–980

    Article  CAS  PubMed  Google Scholar 

  24. Haddy TB, Rana SR, Castro O (1999) Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 133(1):15–22

    Article  CAS  PubMed  Google Scholar 

  25. He J, Guo JP, Ding Y, Li YN, Pan SS, Liu Y et al (2011) Diagnostic significance of measuring antibodies to cyclic type 3 muscarinic acetylcholine receptor peptides in primary Sjogren’s syndrome. Rheumatology 50(5):879–884

    Article  CAS  PubMed  Google Scholar 

  26. Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H, Ikeda Y (2006) Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology 45(7):851–854

    Article  CAS  PubMed  Google Scholar 

  27. Lurie DP, Kahaleh MB (1982) Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus. J Rheumatol 9(2):311–314

    CAS  PubMed  Google Scholar 

  28. Tincani A, Biasini-Rebaioli C, Cattaneo R, Riboldi P (2005) Nonorgan specific autoantibodies and heart damage. Lupus 14(9):656–659

    Article  CAS  PubMed  Google Scholar 

  29. Sarzi-Puttini P, Atzeni F, Gerli R, Bartoloni E, Doria A, Barskova T et al (2010) Cardiac involvement in systemic rheumatic diseases: an update. Autoimmun Rev 9(12):849–852

    Article  PubMed  Google Scholar 

  30. Brigden W, Bywaters EG, Lessof MH, Ross IP (1960) The heart in systemic lupus erythematosus. Br Heart J 22:1–16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kao AH, Manzi S (2002) How to manage patients with cardiopulmonary disease? Best Pract Res Clin Rheumatol 16(2):211–227

    Article  PubMed  Google Scholar 

  32. Godeau P, Guillevin L, Fechner J, Herreman G, Wechsler B (1981) Cardiac involvement in systemic lupus erythematosus. 103 cases (author’s transl). Nouv Press Med 10(26):2175–2178

    CAS  Google Scholar 

  33. Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology 45(Suppl 4):iv8–iv13

    PubMed  Google Scholar 

  34. Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18(3):238–240

    Article  CAS  PubMed  Google Scholar 

  35. Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G (2011) New autoantigens in the antiphospholipid syndrome. Autoimmun Rev 10(10):609–616

    Article  CAS  PubMed  Google Scholar 

  36. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: JTH 4(2):295–306

    Article  CAS  PubMed  Google Scholar 

  37. Ames PR, Antinolfi I, Scenna G, Gaeta G, Margaglione M, Margarita A (2009) Atherosclerosis in thrombotic primary antiphospholipid syndrome. J Thromb Haemost: JTH 7(4):537–542

    Article  CAS  PubMed  Google Scholar 

  38. Giles I, Khamashta M, D’Cruz D, Cohen H (2012) A new dawn of anticoagulation for patients with antiphospholipid syndrome? Lupus 21(12):1263–1265

    Article  PubMed  Google Scholar 

  39. Lopez-Pedrera C, Ruiz-Limon P, Aguirre MA, Rodriguez-Ariza A, Cuadrado MJ (2012) Potential use of statins in the treatment of antiphospholipid syndrome. Curr Rheumatol Rep 14(1):87–94

    Article  CAS  PubMed  Google Scholar 

  40. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 63(5):1182–1189

    Article  CAS  PubMed  Google Scholar 

  41. Souza DC, Santo AH, Sato EI (2012) Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis. J Rheumatol 39(3):496–503

    Article  PubMed  Google Scholar 

  42. Zonana-Nacach A, Camargo-Coronel A, Yanez P, Sanchez L, Jimenez-Balderas FJ, Fraga A (2001) Infections in outpatients with systemic lupus erythematosus: a prospective study. Lupus 10(7):505–510

    Article  CAS  PubMed  Google Scholar 

  43. Kang I, Park SH (2003) Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 15(5):528–534

    Article  CAS  PubMed  Google Scholar 

  44. Gladman DD, Hussain F, Ibanez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11(4):234–239

    Article  CAS  PubMed  Google Scholar 

  45. Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39(9):1475–1482

    Article  CAS  PubMed  Google Scholar 

  46. Zandman-Goddard G, Shoenfeld Y (2005) Infections and SLE. Autoimmunity 38(7):473–485

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center of Research of Immunopathology and Rare Diseases, Coordinating Center of the Network of Rare Diseases of Piedmont and Aosta Valley, Department of Rare, Immunologic, Hematologic and Immunohematologic Diseases, Giovanni Bosco Hospital, University of Turin, Piazza donatore di Sangue 3, Turin, 10154, Italy

    Savino Sciascia

  2. Lupus Research Unit, St. Thomas Hospital, Westminster Bridge, London, Se17EH, UK

    Savino Sciascia & Maria Josè Cuadrado

Authors
  1. Savino Sciascia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Josè Cuadrado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Josè Cuadrado .

Editor information

Editors and Affiliations

  1. Giovanni Bosco Hospital, Center of Immunopathology/Rare Dise, Torino, Torino, Italy

    Dario Roccatello

  2. University of Florence, Florence, Italy

    Lorenzo Emmi

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Sciascia, S., Cuadrado, M.J. (2016). Systemic Lupus Erythematosus: Clinical Aspects. In: Roccatello, D., Emmi, L. (eds) Connective Tissue Disease. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-24535-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24535-5_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24533-1

  • Online ISBN: 978-3-319-24535-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation